Thakore N Patel is a pharmacist who is specialized in Oncology in Joliet, Illinois. Patients can reach him at 2614 W. Jefferson Street, Joliet or contact him on 815-730-3030. Active license number of Thakore N Patel is 051-031106 for Oncology in Illinois. Thakore N Patel is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Thakore N Patel speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Thakore N Patel
Specialization:
Oncology
Credentials:
R.PH.
Gender:
Male
Location:
2614 W. Jefferson Street, Joliet, Illinois, 60435
Phone:
815-730-3030
Fax:
815-725-9450
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Thakore N Patel are as mentioned below.
NPI Number:
1013057157
NPI Enumeration Date:
07 Feb, 2007
NPI Last Update On:
01 Oct, 2013
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Thakore N Patel are as mentioned below.
Specialization
License Number
State
Status
Oncology
051-031106
Illinois
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
2614 W Jefferson Street, Joliet, Illinois
Zip:
60435
Phone Number:
815-730-3030
Fax Number:
815-725-9450
Patients can reach Thakore N Patel at 2614 W. Jefferson Street, Joliet, Illinois or can call on phone at 815-730-3030.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.